Shipments of pharmaceuticals from Bangladesh grew 22.21 percent year on year in the first half of the ongoing fiscal year. According to the Export Promotion Bureau, 105.50 million dollars were exported in the July-December period, which is 19.17 million dollars more compared to the last year’s session which was 86.33 million dollars.
The exports of pharmaceuticals consisted of drawbacks. According to the Freightos FBX Index, in September, a 40-foot container eased some 15 percent from record highs above 11 thousand dollars. According to Reuters, comparing the prices before the covid pandemic, the same container used to cost around 13 hundred dollars in December.
Bangladesh Association of Pharmaceuticals (BAPI) reports that the country exports more than 2000 types of pharma products in over 150 countries. 50 percent of the total exports would include antibiotic and oncological products, where oncological products account for at least 20 percent of the total export earnings of the industry.
Around 20 companies including Eskayef, Beximco, Incepta, Beacon, Square, Popular, Opsonin, ACI, Renata, and Ziska Pharmaceuticals export Covid-19 drugs.
Export surges occurred due to the treatment of Covid-19 patients when the pandemic was declared by the World Health Organization. Antiviral drugs such as Remdesivir and Favipiravir have increased pharmaceutical exports in total.